Optimising surveillance in hepatocellular carcinoma: patient-defined obstacles and solutions
File(s)
Author(s)
Qurashi, Maria
von Wagner, Christian
Sharma, Rohini
Type
Journal Article
Abstract
BACKGROUND AND AIMS: Six-monthly ultrasound surveillance for hepatocellular carcinoma (HCC) is recommended in patients with cirrhosis. Surveillance enhances early detection and improves survival. Yet, despite clear benefits, uptake remains low. We aim to identify and explore ways to overcome patient-related barriers to HCC surveillance with the aim of producing invitations for surveillance. METHODS: Using the COM-B model of behaviour and a co-design process, we collaborated with patients, liver health charities and advocacy groups, to identify patient-related barriers to attending HCC surveillance. We performed qualitative thematic analysis of co-production workshops on HCC surveillance to develop information leaflets and surveillance invitations. RESULTS: Twenty-eight participants attended five workshops. Fear of a serious diagnosis and stigma from healthcare professionals were highlighted as main patient-related barriers to attending surveillance appointments. Co-design was used to develop informative, user-friendly, non-judgemental invitations and information regarding HCC surveillance relevant to populations with cirrhosis. CONCLUSION: We identified potential patient barriers to surveillance uptake and developed patient facing material that directly addressed these barriers to be trialled in the clinic. Targeting patient-specific barriers may increase uptake of surveillance and therefore enhance early diagnosis.
Date Issued
2024
Date Acceptance
2024-07-20
Citation
Journal of Hepatocellular Carcinoma, 2024, 11, pp.1597-1605
ISSN
2253-5969
Publisher
Dove Medical Press
Start Page
1597
End Page
1605
Journal / Book Title
Journal of Hepatocellular Carcinoma
Volume
11
Copyright Statement
© 2024 Qurashi et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.
php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the
work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For
permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the
work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For
permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
License URL
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/39193064
Subjects
co-design
communication
hepatocellular carcinoma
surveillance
Publication Status
Published
Coverage Spatial
New Zealand
Date Publish Online
2024-08-23